By Dipo Olowookere Takeda Pharmaceutical Company Limited has disclosed that the global, randomized, Phase 3 ALTA-1L (ALK in Lung Cancer Trial of AP26113 in 1st Line)...
By Modupe Gbadeyanka Takeda Pharmaceutical Company Limited today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 per share in cash. “We are...
By Dipo Olowookere Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals Inc. today announced that they have entered into a definitive agreement under which Takeda will acquire...
By Modupe Gbadeyanka Japanese firm, Takeda Pharmaceutical Company Limited, has announced that the Biomedical Advanced Research and Development Authority (BARDA) has selected its Vaccine Business Unit...
